Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Bone marrow histomorphologic criteria can accurately diagnose hemophagocytic lymphohistiocytosis.

Gars E, Purington N, Scott G, Chisholm K, Gratzinger D, Martin BA, Ohgami RS.

Haematologica. 2018 Jun 14. pii: haematol.2017.186627. doi: 10.3324/haematol.2017.186627. [Epub ahead of print]

2.

Tumor Formation of Adult Stem Cell Transplants in Rodent Arthritic Joints.

Chapelin F, Khurana A, Moneeb M, Gray Hazard FK, Chan CFR, Nejadnik H, Gratzinger D, Messing S, Erdmann J, Gaur A, Daldrup-Link HE.

Mol Imaging Biol. 2018 Jun 4. doi: 10.1007/s11307-018-1218-7. [Epub ahead of print]

PMID:
29869062
3.

Magnetic Resonance Imaging of Tumor Associated Macrophages: Clinical Translation.

Aghighi M, Theruvath AJ, Pareek A, Pisani L, Alford R, Muehe AM, Sethi TK, Holdsworth SJ, Hazard FK, Gratzinger D, Luna-Fineman S, Advani RH, Spunt SL, Daldrup-Link HE.

Clin Cancer Res. 2018 May 15. pii: clincanres.0673.2018. doi: 10.1158/1078-0432.CCR-18-0673. [Epub ahead of print]

PMID:
29764855
4.

Nodal Involvement by CD30+ Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma.

Lezama LS, Gratzinger D.

Arch Pathol Lab Med. 2018 Jan;142(1):139-142. doi: 10.5858/arpa.2016-0352-RS. Review.

PMID:
29257929
5.

The Recent Pathology Residency Graduate Job Search Experience: A Synthesis of 5 Years of College of American Pathologists Job Market Surveys.

Gratzinger D, Johnson KA, Brissette MD, Cohen D, Rojiani AM, Conran RM, Hoffman RD, Post MD, McCloskey CB, Roberts CA, Domen RE, Talbert ML, Powell SZ.

Arch Pathol Lab Med. 2018 Apr;142(4):490-495. doi: 10.5858/arpa.2017-0207-CP. Epub 2017 Dec 6.

PMID:
29210592
6.

Normative data for flow cytometry immunophenotyping of benign lymph nodes sampled by surgical biopsy.

Scott GD, Atwater SK, Gratzinger DA.

J Clin Pathol. 2018 Feb;71(2):174-179. doi: 10.1136/jclinpath-2017-204687. Epub 2017 Sep 15.

7.

Erratum to: Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Lynch RC, Gratzinger D, Advani RH.

Curr Treat Options Oncol. 2017 Oct;18(10):60. doi: 10.1007/s11864-017-0499-4. No abstract available.

PMID:
28861885
8.

Entrustable Professional Activities for Pathology: Recommendations From the College of American Pathologists Graduate Medical Education Committee.

McCloskey CB, Domen RE, Conran RM, Hoffman RD, Post MD, Brissette MD, Gratzinger DA, Raciti PM, Cohen DA, Roberts CA, Rojiani AM, Kong CS, Peterson JEG, Johnson K, Plath S, Powell SZ.

Acad Pathol. 2017 Jun 27;4:2374289517714283. doi: 10.1177/2374289517714283. eCollection 2017 Jan-Dec.

9.

Perceptions of Unprofessional Attitudes and Behaviors: Implications for Faculty Role Modeling and Teaching Professionalism During Pathology Residency.

Brissette MD, Johnson KA, Raciti PM, McCloskey CB, Gratzinger DA, Conran RM, Domen RE, Hoffman RD, Post MD, Roberts CA, Rojiani AM, Powell SZ.

Arch Pathol Lab Med. 2017 Oct;141(10):1394-1401. doi: 10.5858/arpa.2016-0477-CP. Epub 2017 Jul 7.

PMID:
28686498
10.

Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Lynch RC, Gratzinger D, Advani RH.

Curr Treat Options Oncol. 2017 Jul;18(7):45. doi: 10.1007/s11864-017-0483-z. Review. Erratum in: Curr Treat Options Oncol. 2017 Oct;18(10 ):60.

PMID:
28670664
11.

Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123-131. PubMed PMID: 27736729].

Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE.

Leuk Res. 2017 Aug;59:65. doi: 10.1016/j.leukres.2017.02.007. Epub 2017 May 30. No abstract available.

PMID:
28575698
12.

B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.

de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):153-170. doi: 10.1093/ajcp/aqw216.

PMID:
28395108
13.

EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES.

Am J Clin Pathol. 2017 Feb 1;147(2):129-152. doi: 10.1093/ajcp/aqw214.

PMID:
28395107
14.

Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):204-216. doi: 10.1093/ajcp/aqw215.

PMID:
28395106
15.

T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.

Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):188-203. doi: 10.1093/ajcp/aqw213.

PMID:
28395105
16.

HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.

Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, Natkunam Y, Goodlad JR.

Am J Clin Pathol. 2017 Feb 1;147(2):171-187. doi: 10.1093/ajcp/aqw218.

PMID:
28395104
17.

Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology.

Natkunam Y, Gratzinger D, de Jong D, Chadburn A, Goodlad JR, Chan JK, Said J, Jaffe ES.

Am J Clin Pathol. 2017 Feb 1;147(2):124-128. doi: 10.1093/ajcp/aqw200. No abstract available.

PMID:
28395103
18.

A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.

Gars E, Yousry SM, Babu D, Kurzer JH, George TI, Gratzinger D.

Leuk Lymphoma. 2017 Jul;58(7):1730-1732. doi: 10.1080/10428194.2016.1251590. Epub 2016 Nov 3. No abstract available.

PMID:
27808583
19.

KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study.

Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Jonas BA, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE.

Leuk Res. 2016 Nov;50:123-131. doi: 10.1016/j.leukres.2016.09.012. Epub 2016 Sep 28. Erratum in: Leuk Res. 2017 Aug;59:65.

PMID:
27736729
20.

Professionalism in Pathology: A Case-Based Approach as a Potential Educational Tool.

Domen RE, Johnson K, Conran RM, Hoffman RD, Post MD, Steinberg JJ, Brissette MD, Gratzinger DA, McCloskey CB, Raciti PM, Roberts CA, Rojiani AM, Powell SZ.

Arch Pathol Lab Med. 2017 Feb;141(2):215-219. doi: 10.5858/arpa.2016-0217-CP. Epub 2016 Oct 20.

PMID:
27763788
21.
22.

Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.

Louissaint A Jr, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, Roth CG, Paxton CN, Kim S, Namgyal C, Morin R, Morgan EA, Neuberg DS, South ST, Harris MH, Hasserjian RP, Hochberg EP, Garraway LA, Harris NL, Weinstock DM.

Blood. 2016 Aug 25;128(8):1093-100. doi: 10.1182/blood-2015-12-682591. Epub 2016 Jun 20.

23.

Plasmacytic posttransplant lymphoproliferative disorder with hyperviscosity syndrome in a child after liver transplant.

Yang CH, Gombar S, Twist CJ, Gratzinger D, Esquivel CO, Lau AH.

Hepatology. 2016 Dec;64(6):2250-2252. doi: 10.1002/hep.28657. Epub 2016 Jul 5. No abstract available.

24.

A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.

Reinisch A, Thomas D, Corces MR, Zhang X, Gratzinger D, Hong WJ, Schallmoser K, Strunk D, Majeti R.

Nat Med. 2016 Jul;22(7):812-21. doi: 10.1038/nm.4103. Epub 2016 May 23.

25.

Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma.

Matthews JM, Bhatt S, Patricelli MP, Nomanbhoy TK, Jiang X, Natkunam Y, Gentles AJ, Martinez E, Zhu D, Chapman JR, Cortizas E, Shyam R, Chinichian S, Advani R, Tan L, Zhang J, Choi HG, Tibshirani R, Buhrlage SJ, Gratzinger D, Verdun R, Gray NS, Lossos IS.

Blood. 2016 Jul 14;128(2):239-48. doi: 10.1182/blood-2016-02-696856. Epub 2016 May 5.

26.

Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma.

Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D.

Hum Pathol. 2016 Sep;55:39-43. doi: 10.1016/j.humpath.2016.04.004. Epub 2016 Apr 28.

PMID:
27134111
27.

Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.

Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H.

Am J Clin Pathol. 2016 Apr;145(4):538-51. doi: 10.1093/ajcp/aqw033. Epub 2016 Apr 22.

PMID:
27124944
28.

Selective quantitation of microvessel density reveals sinusoidal expansion in myelodysplastic syndromes.

Ewalt MD, Gratzinger D.

Leuk Lymphoma. 2016 Dec;57(12):2923-2926. Epub 2016 Apr 22. No abstract available.

PMID:
27104365
29.

Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.

Flores-Figueroa E, Gratzinger D.

Int J Mol Sci. 2016 Apr 13;17(4):553. doi: 10.3390/ijms17040553. Review.

30.

Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting.

Gratzinger D, Jaffe ES.

Leuk Lymphoma. 2016 Aug;57(8):1982-3. doi: 10.3109/10428194.2016.1166492. Epub 2016 Apr 13. No abstract available.

PMID:
27071493
31.

Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.

Nybakken GE, Bala R, Gratzinger D, Jones CD, Zehnder JL, Bangs CD, Cherry A, Warnke RA, Natkunam Y.

PLoS One. 2016 Mar 18;11(3):e0151735. doi: 10.1371/journal.pone.0151735. eCollection 2016.

32.

Myelodysplastic syndrome macrophages have aberrant iron storage and heme oxygenase-1 expression.

Nybakken G, Gratzinger D.

Leuk Lymphoma. 2016 Aug;57(8):1893-902. doi: 10.3109/10428194.2015.1121259. Epub 2016 Jan 12.

PMID:
26758041
33.

Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.

Gratzinger D, Million L, Kim YH.

Am J Dermatopathol. 2015 Oct;37(10):767-70. doi: 10.1097/DAD.0000000000000377.

PMID:
26381026
34.

Dasatinib-related Follicular Hyperplasia: An Underrecognized Entity With Characteristic Morphology.

Ozawa MG, Ewalt MD, Gratzinger D.

Am J Surg Pathol. 2015 Oct;39(10):1363-9. doi: 10.1097/PAS.0000000000000488.

PMID:
26360368
35.

Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

Ungewickell A, Bhaduri A, Rios E, Reuter J, Lee CS, Mah A, Zehnder A, Ohgami R, Kulkarni S, Armstrong R, Weng WK, Gratzinger D, Tavallaee M, Rook A, Snyder M, Kim Y, Khavari PA.

Nat Genet. 2015 Sep;47(9):1056-60. doi: 10.1038/ng.3370. Epub 2015 Aug 10.

PMID:
26258847
36.

Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.

LeBlanc RE, Lefterova MI, Suarez CJ, Tavallaee M, Kim YH, Schrijver I, Kim J, Gratzinger D.

Hum Pathol. 2015 Sep;46(9):1382-9. doi: 10.1016/j.humpath.2015.05.024. Epub 2015 Jun 10.

PMID:
26193796
37.

Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival.

Johnson RC, Kurzer JH, Greenberg PL, Gratzinger D.

Am J Clin Pathol. 2014 Dec;142(6):795-802. doi: 10.1309/AJCP71OPHKOTLSUG.

PMID:
25389333
38.

Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.

Samols MA, Su A, Ra S, Cappel MA, Louissant A Jr, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.

Am J Surg Pathol. 2014 Sep;38(9):1203-11. doi: 10.1097/PAS.0000000000000217.

PMID:
24805854
39.

Update on Myelodysplastic Syndromes Classification and Prognosis.

Gratzinger D, Greenberg PL.

Surg Pathol Clin. 2013 Dec;6(4):693-728. doi: 10.1016/j.path.2013.08.005. Epub 2013 Oct 21.

PMID:
26839194
40.

Vascular endothelial growth factor: the salt in the Hodgkin cytokine stew?

Gratzinger D.

Leuk Lymphoma. 2014 Mar;55(3):474-5. doi: 10.3109/10428194.2013.818144. Epub 2013 Jul 29. No abstract available.

PMID:
23795806
41.

Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.

Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D.

Am J Surg Pathol. 2013 Apr;37(4):617-23. doi: 10.1097/PAS.0b013e318280aa9c.

PMID:
23480896
42.

IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report.

Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D.

Ocul Immunol Inflamm. 2012 Oct;20(5):375-7. doi: 10.3109/09273948.2012.709574.

PMID:
23030356
43.

Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow.

Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D.

Lab Invest. 2012 Sep;92(9):1330-41. doi: 10.1038/labinvest.2012.93. Epub 2012 Jun 18.

44.

Histoplasmosis presenting with ulcers on the soft palate.

Ozdalga E, Gratzinger D.

J Gen Intern Med. 2012 Sep;27(9):1219. doi: 10.1007/s11606-012-2042-4. Epub 2012 Apr 27. No abstract available.

45.

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.

Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, Levy R.

Blood. 2012 Jan 12;119(2):355-63. doi: 10.1182/blood-2011-05-355222. Epub 2011 Nov 1.

46.

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.

Luo RF, Zhao S, Tibshirani R, Myklebust JH, Sanyal M, Fernandez R, Gratzinger D, Marinelli RJ, Lu ZS, Wong A, Levy R, Levy S, Natkunam Y.

Hum Pathol. 2010 Feb;41(2):271-80. doi: 10.1016/j.humpath.2009.07.022. Epub 2009 Dec 8.

47.

Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP).

Gratzinger D, Advani R, Zhao S, Talreja N, Tibshirani RJ, Shyam R, Horning S, Sehn LH, Farinha P, Briones J, Lossos IS, Gascoyne RD, Natkunam Y.

Br J Haematol. 2010 Jan;148(2):235-44. doi: 10.1111/j.1365-2141.2009.07942.x. Epub 2009 Oct 11.

48.

VEGF-C: putting the 'lymph' back in lymphoma?

Gratzinger D.

Leuk Lymphoma. 2009 Mar;50(3):311-2. doi: 10.1080/10428190902763525. No abstract available.

PMID:
19347719
49.

The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y.

Am J Clin Pathol. 2009 Feb;131(2):264-78. doi: 10.1309/AJCP5FP3NAXAXRJE.

50.

Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression.

Gratzinger D, Salama ME, Poh CF, Rouse RV.

J Oral Pathol Med. 2008 Mar;37(3):177-84. doi: 10.1111/j.1600-0714.2007.00613.x.

PMID:
18251942

Supplemental Content

Loading ...
Support Center